Price
$7.27
Decreased by -2.02%
Dollar volume (20D)
318.90 K
ADR%
8.49
Earnings report date
Jun 10, 2025
Shares float
4.20 M
Shares short
662.19 K [15.77%]
Shares outstanding
5.86 M
Market cap
42.48 M
Beta
0.30
Price/earnings
N/A
20D range
5.16 8.65
50D range
5.00 8.65
200D range
5.00 18.70

Atara Biotherapeutics, Inc. engages in the development of transformative therapies for patients with cancer and autoimmune disease in the United States and the United Kingdom.

Its lead product includes Tab-cel (tabelecleucel), a T-cell immunotherapy program that is in Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) with post-transplant lymphoproliferative disease, as well as other EBV-driven diseases.

The company has research collaboration agreements with Memorial Sloan Kettering Cancer Center, and Council of the Queensland Institute of Medical Research.

Atara Biotherapeutics, Inc. was incorporated in 2012 and is headquartered in Thousand Oaks, California.

  • Quarterly earnings
  • Annual earnings
Reported date EPSChange YoY EstimateSurprise
Mar 26, 25 -1.19
Decreased by -112.50%
-3.49
Increased by +65.88%
Oct 30, 24 -2.93
Decreased by -343.94%
-17.27
Increased by +83.04%
Aug 12, 24 -3.10
Decreased by -355.88%
-1.56
Decreased by -98.72%
May 9, 24 -0.23
Increased by +68.06%
-0.26
Increased by +11.54%
Mar 28, 24 -0.56
Increased by +22.22%
-0.48
Decreased by -16.67%
Nov 1, 23 -0.66
Increased by +19.51%
-0.66
Aug 8, 23 -0.68
Decreased by -119.35%
-0.67
Decreased by -1.49%
May 8, 23 -0.72
Increased by +17.24%
-0.39
Decreased by -84.62%
  • Quarterly financials
  • Annual financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Dec 31, 24 32.75 M
Increased by +670.30%
-12.69 M
Increased by +97.90%
Decreased by -38.75%
Increased by +99.73%
Sep 30, 24 40.19 M
Increased by +1.78 K%
-21.91 M
Increased by +96.86%
Decreased by -54.51%
Increased by +99.83%
Jun 30, 24 28.64 M
Increased by +2.89 K%
-19.05 M
Increased by +97.32%
Decreased by -66.51%
Increased by +99.91%
Mar 31, 24 27.36 M
Increased by +2.13 K%
-317.52 M
Increased by +57.53%
Decreased by -1.16 K%
Increased by +98.10%
Dec 31, 23 4.25 M
Increased by +1.82 K%
-604.50 M
Increased by +18.94%
Decreased by -14.22 K%
Increased by +95.79%
Sep 30, 23 2.14 M
Decreased by -52.05%
-697.97 M
Increased by +17.00%
Decreased by -32.65 K%
Decreased by -73.11%
Jun 30, 23 957.00 K
Decreased by -98.14%
-711.08 M
Decreased by -485.08%
Decreased by -74.30 K%
Decreased by -20.85 K%
Mar 31, 23 1.23 M
Decreased by -83.24%
-747.71 M
Increased by +15.13%
Decreased by -60.99 K%
Decreased by -406.29%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY